Literature DB >> 20192868

The effect of metformin on alveolar bone in ligature-induced periodontitis in rats: a pilot study.

Eun Jung Bak1, Hong Gyu Park, Minyoung Kim, Sung Whan Kim, Sungwuk Kim, Seong-Ho Choi, Jeong-Heon Cha, Yun-Jung Yoo.   

Abstract

BACKGROUND: The use of metformin, an antidiabetic agent, is associated with a reduced risk of fractures in patients with diabetes, suggesting that metformin exerts a beneficial effect on bone tissues. The objective of this study was to assess the effect of metformin on alveolar bone loss in ligature-induced periodontitis and osteoblast, osteoclast, and adipocyte differentiation.
METHODS: Periodontitis was induced by a ligature around the mandibular first molar of each rat. The rats were divided into two groups: 1) rats with ligature receiving a vehicle (n = 5), and 2) rats with ligature receiving metformin (n = 5). On day 10, after the induction of periodontitis, the alveolar bone volume between the first and second molar was determined via microcomputed tomography. The effect of metformin on osteoblast, osteoclast, and adipocyte differentiation was assessed using MC3T3-E1, cocultures of mouse bone marrow cells and calvaria-derived osteoblasts, and 3T3-L1/C3H10T1/2 cells, respectively. Osteoblast, osteoclast, and adipocyte differentiation was estimated by the degree of mineralization, the formation of tartrate-resistant acid phosphatase-positive multinucleated cells, and the accumulation of triglycerides, respectively.
RESULTS: In ligature-induced periodontitis, the metformin treatment of rats induced a significant reduction in alveolar bone loss compared to vehicle-treated rats. With regard to osteoblast differentiation, metformin augmented the mineralization of MC3T3-E1 cells approximately two-fold over the non-treated cells. However, metformin was shown to exert no effects on osteoclast formation induced by 1,25-dihydroxyvitamin D(3), lipopolysaccharide, and prostaglandin E(2). Moreover, metformin exerted no effect on adipocyte differentiation.
CONCLUSION: Our findings suggest that metformin may exert a beneficial effect on alveolar bone in periodontitis by increasing osteoblast differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192868     DOI: 10.1902/jop.2009.090414

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  14 in total

1.  Periodontal Disease Impairs Muscle Recovery by Modulating the Recruitment of Leukocytes.

Authors:  Bárbara Capitanio de Souza; Bibiana Franzen Matte; André Luiz Lopes; Bruno Costa Teixeira; Marcelo Lazzaron Lamers
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

2.  Effect of adjuvant use of metformin on periodontal treatment: a systematic review and meta-analysis.

Authors:  Alessandra Cardoso Nicolini; Thaise Americo Grisa; Francisco Wilker Mustafa Gomes Muniz; Cassiano Kuchenbecker Rösing; Juliano Cavagni
Journal:  Clin Oral Investig       Date:  2018-10-16       Impact factor: 3.573

Review 3.  Diabetes pharmacotherapy and effects on the musculoskeletal system.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Iuliana Popescu; Kathryn M Thrailkill
Journal:  Diabetes Metab Res Rev       Date:  2018-12-20       Impact factor: 4.876

4.  The effects of metformin on the bone filling ration around of TiAl6Va4 implants in non diabetic rats.

Authors:  Tuba Talo Yıldırım; Serkan Dündar; Alihan Bozoğlan; Tahir Karaman; Onur Evren Kahraman; Erhan Cahit Özcan
Journal:  J Oral Biol Craniofac Res       Date:  2020-08-08

5.  Therapeutic Potential of Liraglutide for Diabetes-Periodontitis Comorbidity: Killing Two Birds with One Stone.

Authors:  Man Yang; Yunqing Pang; Minyu Pei; Yuanyuan Li; Xuemin Yuan; Rongbing Tang; Jing Wang
Journal:  J Diabetes Res       Date:  2022-07-06       Impact factor: 4.061

6.  Metformin Hydrochloride-Loaded PLGA Nanoparticle in Periodontal Disease Experimental Model Using Diabetic Rats.

Authors:  Aline de Sousa Barbosa Freitas Pereira; Gerly Anne de Castro Brito; Maria Laura de Souza Lima; Arnóbio Antônio da Silva Júnior; Emanuell Dos Santos Silva; Adriana Augusto de Rezende; Raul Hernandes Bortolin; Maria Galvan; Flávia Q Pirih; Raimundo Fernandes de Araújo Júnior; Caroline Addison Carvalho Xavier de Medeiros; Gerlane Coelho Bernando Guerra; Aurigena Antunes de Araújo
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

7.  The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing.

Authors:  J Jeyabalan; B Viollet; P Smitham; S A Ellis; G Zaman; C Bardin; A Goodship; J P Roux; M Pierre; C Chenu
Journal:  Osteoporos Int       Date:  2013-05-04       Impact factor: 4.507

8.  Osteogenic action of anti-diabetic drug metformin in periodontal disease.

Authors:  Ashish Agarwal
Journal:  J Pharm Bioallied Sci       Date:  2013-10

Review 9.  Efficacy of metformin in the management of periodontitis: A systematic review and meta-analysis.

Authors:  Shariq Najeeb; Muhammad Sohail Zafar; Zohaib Khurshid; Sana Zohaib; Sreenath Arekunnath Madathil; Maria Mali; Khalid Almas
Journal:  Saudi Pharm J       Date:  2018-02-16       Impact factor: 4.330

10.  Metformin coordinates osteoblast/osteoclast differentiation associated with ischemic osteonecrosis.

Authors:  See-Hyoung Park; Mi-Ae Kang; Young Jae Moon; Kyu Yun Jang; Jung Ryul Kim
Journal:  Aging (Albany NY)       Date:  2020-02-11       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.